Roche Holding AG - ESG Rating & Company Profile powered by AI
This ESG score includes 17 United Nations SDGs including: 'Affordable & Clean Energy', 'Sustainable Cities & Communities' and 'Partnerships for the Goals'. This page includes a questions and answers table about Roche Holding AG. Check the bottom of this page for potential risks for Roche Holding AG based on sector, location and marketcap.
Roche Holding AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.3; made up of an environmental score of 7.0, social score of 7.0 and governance score of 8.0.
7.3
High ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 160 | YungShin Global Holding Corp | 7.5 | High |
| 160 | Zentiva SA | 7.5 | High |
| 191 | Roche Holding AG | 7.3 | High |
| 191 | Cellectis SA | 7.3 | High |
| 191 | Aurinia Pharmaceuticals Inc | 7.3 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Roche Holding AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Roche Holding AG disclose current and historical energy intensity?
Sign up for free to unlockDoes Roche Holding AG report the average age of the workforce?
Sign up for free to unlockDoes Roche Holding AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Roche Holding AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes Roche Holding AG disclose cybersecurity risks?
Sign up for free to unlockDoes Roche Holding AG offer flexible work?
Sign up for free to unlockDoes Roche Holding AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Roche Holding AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Roche Holding AG conduct supply chain audits?
Sign up for free to unlockDoes Roche Holding AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Roche Holding AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes Roche Holding AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes Roche Holding AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Roche Holding AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Roche Holding AG disclose water use targets?
Sign up for free to unlockDoes Roche Holding AG have careers partnerships with academic institutions?
Sign up for free to unlockDid Roche Holding AG have a product recall in the last two years?
Sign up for free to unlockDoes Roche Holding AG disclose incidents of discrimination?
Sign up for free to unlockDoes Roche Holding AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Roche Holding AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Roche Holding AG disclose parental leave metrics?
Sign up for free to unlockDoes Roche Holding AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Roche Holding AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Roche Holding AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes Roche Holding AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Roche Holding AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Roche Holding AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Roche Holding AG involved in embryonic stem cell research?
Sign up for free to unlockDoes Roche Holding AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Roche Holding AG disclose its waste policy?
Sign up for free to unlockDoes Roche Holding AG report according to TCFD requirements?
Sign up for free to unlockDoes Roche Holding AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Roche Holding AG disclose energy use targets?
Sign up for free to unlockDoes Roche Holding AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Roche Holding AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Roche Holding AG
These potential risks are based on the size, segment and geographies of the company.
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.